EX-99.1
Published on July 9, 2021
Exhibit 1
Joint Filing Agreement
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Graphite Bio, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
| July 9, 2021 |
||
| Versant Venture Capital VI, L.P. |
||
| By: |
Versant Ventures VI GP, L.P. |
|
| Its: |
General Partner |
|
| By: |
Versant Ventures VI GP-GP, LLC |
|
| Its: |
General Partner |
|
| By: |
/s/ Robin L. Praeger, Managing Director |
|
| Versant Ventures VI GP, L.P. |
||
| By: |
Versant Ventures VI GP-GP, LLC |
|
| Its: |
General Partner |
|
| By: |
/s/ Robin L. Praeger, Managing Director |
|
| Versant Ventures VI GP-GP, LLC |
||
| By: |
/s/ Robin L. Praeger, Managing Director |
|
| Versant Vantage II, L.P. |
||
| By: |
Versant Vantage II GP, L.P. |
|
| Its: |
General Partner |
|
| By: |
Versant Vantage II GP-GP, LLC |
|
| Its: |
General Partner |
|
| By: |
/s/ Robin L. Praeger, Managing Director |
|
| Versant Vantage II GP, L.P. |
||
| By: |
Versant Vantage II GP-GP, LLC |
|
| Its: |
General Partner |
|
| By: |
/s/ Robin L. Praeger, Managing Director |
|
| Versant Vantage II GP-GP, LLC |
||
| By: |
/s/ Robin L. Praeger, Managing Director |
|